Thomas P Burke

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Candida Albicans

Top Venues

bioRxiv : the preprint server for biology

Science advances

Nature microbiology

University of California, Berkeley

University of California, Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California, Berkeley Sep 01 2015

United States

Postdoc :: Molecular and Cell Biology

Education History

University of California, Berkeley Sep 01 2009 - May 01 2015

United States

PHD :: Molecular and Cell Biology

Indiana University Sep 01 2005 - May 01 2009

United States

BSC :: Spanish

Indiana University Sep 01 2005 - May 01 2009

United States

BSC :: Biology

Publications

Meggie Danielson, Chris J Nicolai, Thaomy T Vo, Natalie Wolf, Thomas P Burke
Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies. bioRxiv : the preprint server for biology (2024)
Meggie Danielson, Chris J Nicolai, Thaomy T Vo, Natalie Wolf, Thomas P Burke
Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies. bioRxiv : the preprint server for biology (2024)
Gina M Borgo, Thomas P Burke, Cuong J Tran, Nicholas T N Lo, Patrik Engström, Matthew D Welch
A patatin-like phospholipase mediates Rickettsia parkeri escape from host membranes. Nature communications 13 (1) (2022)
Patrik Engström, Thomas P Burke, Cuong J Tran, Anthony T Iavarone, Matthew D Welch
Lysine methylation shields an intracellular pathogen from ubiquitylation and autophagy. Science advances 7 (26) (2021)
Thomas P Burke, Patrik Engström, Cuong J Tran, Ingeborg M Langohr, Dustin R Glasner, Diego A Espinosa, Eva Harris, Matthew D Welch
Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis. eLife 10 (2021)
Thomas P Burke, Patrik Engström, Roberto A Chavez, Joshua A Fonbuena, Russell E Vance, Matthew D Welch
Inflammasome-mediated antagonism of type I interferon enhances Rickettsia pathogenesis. Nature microbiology 5 (5) (2020)